Nicholas Investment Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
KFO
Nicholas Investment Partners's NEO Position: Q1 2022 in Review
Nicholas Investment Partners sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 428,378 shares — an estimated $14.6M sold.
Nicholas Investment Partners first reported a position in NEO in Q3 2014 and held it in 23 quarters. The position peaked at $22.7M in Q1 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Nicholas Investment Partners reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- Nicholas Investment Partners sold 428,378 NeoGenomics shares in Q1 2022, an estimated $14.6M.
- Nicholas Investment Partners first reported a position in NeoGenomics in Q3 2014 and held it in 23 quarters.
- Nicholas Investment Partners's NeoGenomics position peaked at $22.7M in Q1 2021.
- 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Nicholas Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.